drugset / Trial / NCT05444257
A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the long-term safety, tolerability, and efficacy of VX-121/tezacaftor/deutivacaftor (VX-121/TEZ/D-IVA) in participants with cystic fibrosis.
Timeline
- Start
- 2022-11-08
- Primary completion
- 2026-10-30
- Completion
- 2026-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vanzacaftor | Small molecule | — | Oral |
| Subject | deutivacaftor | Unknown | — | Oral |
| Subject | tezacaftor | Other / unclassified | — | Oral |